This Article Full Text Full Text (PDF) Supplementary Data Correction (v67,p5578) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morey, S. R. Articles by Karpf, A. R. Search for Related Content PubMed PubMed Citation Articles by Morey, S. R. Articles by Karpf, A. R.

DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer

Departments of ¹ Pharmacology and Therapeutics and ² Cancer Genetics, Roswell Park Cancer Institute; and ³ Department of Biostatistics, State University of New York at Buffalo, Buffalo, New York

Requests for reprints: Adam R. Karpf, Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 719-845-8305; Fax: 716-845-8857; E-mail: adam.karpf{at}roswellpark.org.

We examined the DNA methylation pathway in an autochthonous murine prostate cancer model, transgenic adenocarcinoma of mouse prostate (TRAMP). We observed that, compared with strain-matched normal prostates, primary and metastatic TRAMP tumors display increased cytosine DNA methyltransferase (Dnmt) activity, Dnmt1 and Dnmt3b protein expression, and Dnmt1, Dnmt3a, and Dnmt3b mRNA expression. Increased expression of Dnmt genes correlates with increased expression of cyclin A and E2F target genes, implicating increased cell proliferation and Rb inactivation in Dnmt overexpression. We analyzed DNA methylation in TRAMP and found that global levels of 5-methyl-2'-deoxycytidine are unaltered, whereas specific tumors display centromeric repeat hypomethylation. To interrogate locus-specific methylation, we did restriction landmark genomic scanning (RLGS) on normal prostates and primary tumors. In primary tumors, 2.3% of 1,200 analyzed loci display aberrant DNA hypermethylation, whereas a considerably smaller number of events show hypomethylation. The pattern of RLGS changes was nonrandom, indicating a coordinated methylation defect. Two specific genes identified by RLGS were studied in detail. Surprisingly, methylation of a downstream exon of p16(INK4a) (p16) was the highest frequency hypermethylation event identified in TRAMP, where it is associated with increased p16 mRNA and protein expression. In contrast, hypermethylation of the 5' CpG island region of the homeobox gene Irx3 in TRAMP is associated with reduced gene expression. In summary, our data reveal a systemic DNA methylation pathway defect in TRAMP reminiscent of human prostate cancer, supporting the use of this model to investigate the functional role of DNA methylation pathway alterations in prostate cancer development. (Cancer Res 2006; 66(24): 11659-67)

This article has been cited by other articles:

				S. R. Morey Kinney, D. J. Smiraglia, S. R. James, M. T. Moser, B. A. Foster, and A. R. Karpf Stage-Specific Alterations of DNA Methyltransferase Expression, DNA Hypermethylation, and DNA Hypomethylation during Prostate Cancer Progression in the Transgenic Adenocarcinoma of Mouse Prostate Model Mol. Cancer Res., August 1, 2008; 6(8): 1365 - 1374. [Abstract] [Full Text] [PDF]

				M. Camoriano, S. R. Morey Kinney, M. T. Moser, B. A. Foster, J. L. Mohler, D. L. Trump, A. R. Karpf, and D. J. Smiraglia Phenotype-Specific CpG Island Methylation Events in a Murine Model of Prostate Cancer Cancer Res., June 1, 2008; 68(11): 4173 - 4182. [Abstract] [Full Text] [PDF]

				Correction: DNA Methylation Changes in TRAMP Cancer Res., June 1, 2007; 67(11): 5578 - 5578. [Full Text] [PDF]